<SEC-DOCUMENT>0001104659-20-000373.txt : 20200102
<SEC-HEADER>0001104659-20-000373.hdr.sgml : 20200102
<ACCEPTANCE-DATETIME>20200102163335
ACCESSION NUMBER:		0001104659-20-000373
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200101
FILED AS OF DATE:		20200102
DATE AS OF CHANGE:		20200102

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gilon Ohev-Zion Michal
		CENTRAL INDEX KEY:			0001796327

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		20501932

	MAIL ADDRESS:	
		STREET 1:		1/3 HIGH-TECH VILLAGE
		STREET 2:		GIVAT RAM, P.O. BOX 39264
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9139102

	FORMER NAME:	
		FORMER CONFORMED NAME:	Ohev-Zion Michal Gilon
		DATE OF NAME CHANGE:	20191209

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anchiano Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1/3 HIGH-TECH VILLAGE
		STREET 2:		GIVAT RAM, P.0. BOX 39264
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9139102
		BUSINESS PHONE:		972-2-5486555

	MAIL ADDRESS:	
		STREET 1:		1/3 HIGH-TECH VILLAGE
		STREET 2:		GIVAT RAM, P.0. BOX 39264
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9139102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tm1927374-8_3.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-01-01</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001534248</issuerCik>
        <issuerName>Anchiano Therapeutics Ltd.</issuerName>
        <issuerTradingSymbol>ANCN</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001796327</rptOwnerCik>
            <rptOwnerName>Gilon Ohev-Zion Michal</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ANCHIANO THERAPEUTICS LTD.</rptOwnerStreet1>
            <rptOwnerStreet2>5 KIRYAT HAMADA ST., P.O. BOX 45032</rptOwnerStreet2>
            <rptOwnerCity>JERUSALEM</rptOwnerCity>
            <rptOwnerState>L3</rptOwnerState>
            <rptOwnerZipCode>9777401</rptOwnerZipCode>
            <rptOwnerStateDescription>ISRAEL</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>VP, Research and Development</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Employee stock options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>67.03</value>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2021-03-06</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>236</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee stock options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>23.91</value>
                <footnoteId id="F4"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2023-03-06</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1766</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee stock options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>6.79</value>
                <footnoteId id="F6"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F5"/>
            </exerciseDate>
            <expirationDate>
                <value>2024-05-10</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>2252</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee stock options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.13</value>
                <footnoteId id="F8"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F7"/>
            </exerciseDate>
            <expirationDate>
                <value>2025-04-28</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>3000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee stock options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.60</value>
                <footnoteId id="F10"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F9"/>
            </exerciseDate>
            <expirationDate>
                <value>2027-09-09</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>40000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee stock options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.03</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F11"/>
            </exerciseDate>
            <expirationDate>
                <value>2029-07-02</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>53000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">1/16 of the options vest at the end of each calendar quarter until fully vested, beginning on March 6, 2011.</footnote>
        <footnote id="F2">The exercise price was converted from New Israeli Shekel (&quot;NIS&quot;) 242.03 using the closing rate of exchange of the Bank of Israel on the date of grant. The actual exercise price is the NIS amount regardless of the exchange rate on the date of exercise.</footnote>
        <footnote id="F3">1/16 of the options vest at the end of each calendar quarter until fully vested, beginning on March 7, 2013.</footnote>
        <footnote id="F4">The exercise price was converted from New Israeli Shekel (&quot;NIS&quot;) 86.62 using the closing rate of exchange of the Bank of Israel on the date of grant. The actual exercise price is the NIS amount regardless of the exchange rate on the date of exercise.</footnote>
        <footnote id="F5">1/16 of the options vest at the end of each calendar quarter until fully vested, beginning on March 2, 2014.</footnote>
        <footnote id="F6">The exercise price was converted from NIS 23.44 using the closing rate of exchange of the Bank of Israel on the date of grant. The actual exercise price is the NIS amount regardless of the exchange rate on the date of exercise.</footnote>
        <footnote id="F7">1/16 of the options vest at the end of each calendar quarter until fully vested, beginning on February 22, 2015.</footnote>
        <footnote id="F8">The exercise price was converted from NIS 12.10 using the closing rate of exchange of the Bank of Israel on the date of grant. The actual exercise price is the NIS amount regardless of the exchange rate on the date of exercise.</footnote>
        <footnote id="F9">1/4 of the options vest one year following the vesting commencement date of September 10, 2017, and 1/16 at the end of each calendar quarter thereafter, until fully vested.</footnote>
        <footnote id="F10">The exercise price was converted from NIS 9.10 using the closing rate of exchange of the Bank of Israel on the date of grant. The actual exercise price is the NIS amount regardless of the exchange rate on the date of exercise.</footnote>
        <footnote id="F11">1/16 of the options vest at the end of each calendar quarter until fully vested, beginning on May 21, 2019.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Michal Gilon</signatureName>
        <signatureDate>2020-01-02</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
